nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0954	0.133	CbGbCtD
Ergonovine—CYP3A4—Estropipate—osteoporosis	0.0887	0.124	CbGbCtD
Ergonovine—CYP3A4—Calcitriol—osteoporosis	0.0887	0.124	CbGbCtD
Ergonovine—CYP3A4—Ergocalciferol—osteoporosis	0.0709	0.099	CbGbCtD
Ergonovine—ABCB1—Conjugated Estrogens—osteoporosis	0.07	0.0978	CbGbCtD
Ergonovine—ABCB1—Estradiol—osteoporosis	0.0615	0.0859	CbGbCtD
Ergonovine—CYP3A4—Raloxifene—osteoporosis	0.0592	0.0827	CbGbCtD
Ergonovine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0572	0.0798	CbGbCtD
Ergonovine—CYP3A4—Cholecalciferol—osteoporosis	0.0457	0.0638	CbGbCtD
Ergonovine—CYP3A4—Conjugated Estrogens—osteoporosis	0.042	0.0586	CbGbCtD
Ergonovine—CYP3A4—Estradiol—osteoporosis	0.0368	0.0514	CbGbCtD
Ergonovine—Vasospasm—Calcium Acetate—osteoporosis	0.0228	0.082	CcSEcCtD
Ergonovine—Cramps of lower extremities—Etidronic acid—osteoporosis	0.0047	0.0169	CcSEcCtD
Ergonovine—Drug interaction—Alendronate—osteoporosis	0.0047	0.0169	CcSEcCtD
Ergonovine—Haematuria—Calcium Acetate—osteoporosis	0.00416	0.0149	CcSEcCtD
Ergonovine—Cramps of lower extremities—Estropipate—osteoporosis	0.00407	0.0146	CcSEcCtD
Ergonovine—Bradycardia—Calcium Acetate—osteoporosis	0.00398	0.0143	CcSEcCtD
Ergonovine—Cramps of lower extremities—Raloxifene—osteoporosis	0.00394	0.0142	CcSEcCtD
Ergonovine—Pulmonary oedema—Ibandronate—osteoporosis	0.00378	0.0136	CcSEcCtD
Ergonovine—Thrombophlebitis—Estropipate—osteoporosis	0.00371	0.0133	CcSEcCtD
Ergonovine—Cramps of lower extremities—Risedronate—osteoporosis	0.00321	0.0115	CcSEcCtD
Ergonovine—Pulmonary oedema—Pamidronate—osteoporosis	0.00296	0.0106	CcSEcCtD
Ergonovine—Thrombophlebitis—Pamidronate—osteoporosis	0.00279	0.01	CcSEcCtD
Ergonovine—Shock—Calcium Acetate—osteoporosis	0.00274	0.00983	CcSEcCtD
Ergonovine—Cramps of lower extremities—Conjugated Estrogens—osteoporosis	0.00269	0.00965	CcSEcCtD
Ergonovine—Hypertension—Ergocalciferol—osteoporosis	0.0026	0.00934	CcSEcCtD
Ergonovine—Hypotension—Calcium Acetate—osteoporosis	0.0026	0.00934	CcSEcCtD
Ergonovine—Hallucination—Etidronic acid—osteoporosis	0.00256	0.00919	CcSEcCtD
Ergonovine—Drug interaction—Estradiol—osteoporosis	0.00252	0.00907	CcSEcCtD
Ergonovine—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.00245	0.00881	CcSEcCtD
Ergonovine—Acute coronary syndrome—Estropipate—osteoporosis	0.00244	0.00877	CcSEcCtD
Ergonovine—Myocardial infarction—Estropipate—osteoporosis	0.00243	0.00872	CcSEcCtD
Ergonovine—Sweating—Raloxifene—osteoporosis	0.0023	0.00826	CcSEcCtD
Ergonovine—Sweating—Ibandronate—osteoporosis	0.00228	0.00818	CcSEcCtD
Ergonovine—Muscle spasms—Etidronic acid—osteoporosis	0.00215	0.00773	CcSEcCtD
Ergonovine—Cramps of lower extremities—Estradiol—osteoporosis	0.00215	0.00773	CcSEcCtD
Ergonovine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00198	0.00711	CcSEcCtD
Ergonovine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00197	0.00707	CcSEcCtD
Ergonovine—Thrombophlebitis—Estradiol—osteoporosis	0.00196	0.00705	CcSEcCtD
Ergonovine—Diarrhoea—Calcium Acetate—osteoporosis	0.0019	0.00684	CcSEcCtD
Ergonovine—Nasal congestion—Estradiol—osteoporosis	0.00187	0.0067	CcSEcCtD
Ergonovine—Muscle spasms—Estropipate—osteoporosis	0.00186	0.00668	CcSEcCtD
Ergonovine—Dizziness—Calcium Acetate—osteoporosis	0.00184	0.00661	CcSEcCtD
Ergonovine—Muscle spasms—Alendronate—osteoporosis	0.00183	0.00658	CcSEcCtD
Ergonovine—Muscle spasms—Raloxifene—osteoporosis	0.0018	0.00648	CcSEcCtD
Ergonovine—Muscle spasms—Ibandronate—osteoporosis	0.00178	0.00641	CcSEcCtD
Ergonovine—Haematuria—Pamidronate—osteoporosis	0.00177	0.00637	CcSEcCtD
Ergonovine—Vomiting—Calcium Acetate—osteoporosis	0.00177	0.00635	CcSEcCtD
Ergonovine—Vertigo—Estropipate—osteoporosis	0.00174	0.00625	CcSEcCtD
Ergonovine—Vertigo—Alendronate—osteoporosis	0.00171	0.00615	CcSEcCtD
Ergonovine—Palpitations—Estropipate—osteoporosis	0.00171	0.00614	CcSEcCtD
Ergonovine—Vertigo—Raloxifene—osteoporosis	0.00168	0.00605	CcSEcCtD
Ergonovine—Vertigo—Ibandronate—osteoporosis	0.00167	0.00599	CcSEcCtD
Ergonovine—Nausea—Calcium Acetate—osteoporosis	0.00165	0.00593	CcSEcCtD
Ergonovine—Palpitations—Ibandronate—osteoporosis	0.00164	0.00589	CcSEcCtD
Ergonovine—Tinnitus—Risedronate—osteoporosis	0.00164	0.00589	CcSEcCtD
Ergonovine—Chest pain—Alendronate—osteoporosis	0.00162	0.00583	CcSEcCtD
Ergonovine—Haematuria—Zoledronate—osteoporosis	0.00162	0.00582	CcSEcCtD
Ergonovine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00161	0.0058	CcSEcCtD
Ergonovine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.0016	0.00576	CcSEcCtD
Ergonovine—Hypertension—Ibandronate—osteoporosis	0.0016	0.00576	CcSEcCtD
Ergonovine—Chest pain—Raloxifene—osteoporosis	0.0016	0.00573	CcSEcCtD
Ergonovine—Chest pain—Ibandronate—osteoporosis	0.00158	0.00568	CcSEcCtD
Ergonovine—Hypertension—Calcitriol—osteoporosis	0.00157	0.00564	CcSEcCtD
Ergonovine—Bradycardia—Zoledronate—osteoporosis	0.00155	0.00558	CcSEcCtD
Ergonovine—Chest pain—Calcitriol—osteoporosis	0.00155	0.00556	CcSEcCtD
Ergonovine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00151	0.00542	CcSEcCtD
Ergonovine—Shock—Raloxifene—osteoporosis	0.0015	0.00541	CcSEcCtD
Ergonovine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00149	0.00536	CcSEcCtD
Ergonovine—Shock—Ibandronate—osteoporosis	0.00149	0.00535	CcSEcCtD
Ergonovine—Hyperhidrosis—Raloxifene—osteoporosis	0.00148	0.00531	CcSEcCtD
Ergonovine—Muscle spasms—Risedronate—osteoporosis	0.00147	0.00528	CcSEcCtD
Ergonovine—Hyperhidrosis—Ibandronate—osteoporosis	0.00146	0.00526	CcSEcCtD
Ergonovine—Nausea—Ergocalciferol—osteoporosis	0.00146	0.00524	CcSEcCtD
Ergonovine—Abdominal pain—Etidronic acid—osteoporosis	0.00144	0.00519	CcSEcCtD
Ergonovine—Muscle spasms—Pamidronate—osteoporosis	0.0014	0.00502	CcSEcCtD
Ergonovine—Vertigo—Risedronate—osteoporosis	0.00137	0.00494	CcSEcCtD
Ergonovine—Hypertension—Risedronate—osteoporosis	0.00132	0.00474	CcSEcCtD
Ergonovine—Chest pain—Risedronate—osteoporosis	0.0013	0.00468	CcSEcCtD
Ergonovine—Gastrointestinal pain—Estropipate—osteoporosis	0.00129	0.00464	CcSEcCtD
Ergonovine—Acute coronary syndrome—Estradiol—osteoporosis	0.00129	0.00464	CcSEcCtD
Ergonovine—Myocardial infarction—Estradiol—osteoporosis	0.00128	0.00461	CcSEcCtD
Ergonovine—Muscle spasms—Zoledronate—osteoporosis	0.00128	0.00459	CcSEcCtD
Ergonovine—Gastrointestinal pain—Alendronate—osteoporosis	0.00127	0.00457	CcSEcCtD
Ergonovine—Hypertension—Pamidronate—osteoporosis	0.00125	0.00451	CcSEcCtD
Ergonovine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00125	0.00449	CcSEcCtD
Ergonovine—Diarrhoea—Etidronic acid—osteoporosis	0.00125	0.00449	CcSEcCtD
Ergonovine—Haematuria—Estradiol—osteoporosis	0.00125	0.00449	CcSEcCtD
Ergonovine—Abdominal pain—Estropipate—osteoporosis	0.00125	0.00449	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00124	0.00445	CcSEcCtD
Ergonovine—Abdominal pain—Alendronate—osteoporosis	0.00123	0.00442	CcSEcCtD
Ergonovine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00123	0.00442	CcSEcCtD
Ergonovine—Shock—Risedronate—osteoporosis	0.00123	0.00441	CcSEcCtD
Ergonovine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00121	0.00436	CcSEcCtD
Ergonovine—Abdominal pain—Raloxifene—osteoporosis	0.00121	0.00435	CcSEcCtD
Ergonovine—Abdominal pain—Ibandronate—osteoporosis	0.0012	0.0043	CcSEcCtD
Ergonovine—Vertigo—Zoledronate—osteoporosis	0.00119	0.00429	CcSEcCtD
Ergonovine—Palpitations—Zoledronate—osteoporosis	0.00117	0.00422	CcSEcCtD
Ergonovine—Abdominal pain—Calcitriol—osteoporosis	0.00117	0.00421	CcSEcCtD
Ergonovine—Shock—Pamidronate—osteoporosis	0.00117	0.00419	CcSEcCtD
Ergonovine—Vomiting—Etidronic acid—osteoporosis	0.00116	0.00417	CcSEcCtD
Ergonovine—Vertigo—Conjugated Estrogens—osteoporosis	0.00115	0.00413	CcSEcCtD
Ergonovine—Hyperhidrosis—Pamidronate—osteoporosis	0.00115	0.00412	CcSEcCtD
Ergonovine—Hypertension—Zoledronate—osteoporosis	0.00115	0.00412	CcSEcCtD
Ergonovine—Headache—Etidronic acid—osteoporosis	0.00114	0.00411	CcSEcCtD
Ergonovine—Chest pain—Zoledronate—osteoporosis	0.00113	0.00406	CcSEcCtD
Ergonovine—Palpitations—Conjugated Estrogens—osteoporosis	0.00113	0.00406	CcSEcCtD
Ergonovine—Dyspnoea—Risedronate—osteoporosis	0.00111	0.004	CcSEcCtD
Ergonovine—Hypotension—Pamidronate—osteoporosis	0.00111	0.00398	CcSEcCtD
Ergonovine—Tinnitus—Estradiol—osteoporosis	0.0011	0.00394	CcSEcCtD
Ergonovine—Chest pain—Conjugated Estrogens—osteoporosis	0.00109	0.00391	CcSEcCtD
Ergonovine—Nausea—Etidronic acid—osteoporosis	0.00108	0.0039	CcSEcCtD
Ergonovine—Diarrhoea—Estropipate—osteoporosis	0.00108	0.00388	CcSEcCtD
Ergonovine—Shock—Zoledronate—osteoporosis	0.00107	0.00383	CcSEcCtD
Ergonovine—Diarrhoea—Alendronate—osteoporosis	0.00106	0.00382	CcSEcCtD
Ergonovine—Dyspnoea—Pamidronate—osteoporosis	0.00106	0.0038	CcSEcCtD
Ergonovine—Hyperhidrosis—Zoledronate—osteoporosis	0.00105	0.00376	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00105	0.00376	CcSEcCtD
Ergonovine—Diarrhoea—Raloxifene—osteoporosis	0.00105	0.00376	CcSEcCtD
Ergonovine—Dizziness—Estropipate—osteoporosis	0.00104	0.00375	CcSEcCtD
Ergonovine—Diarrhoea—Ibandronate—osteoporosis	0.00104	0.00372	CcSEcCtD
Ergonovine—Dizziness—Alendronate—osteoporosis	0.00103	0.0037	CcSEcCtD
Ergonovine—Shock—Conjugated Estrogens—osteoporosis	0.00103	0.00369	CcSEcCtD
Ergonovine—Gastrointestinal pain—Risedronate—osteoporosis	0.00102	0.00367	CcSEcCtD
Ergonovine—Diarrhoea—Calcitriol—osteoporosis	0.00101	0.00364	CcSEcCtD
Ergonovine—Hypotension—Zoledronate—osteoporosis	0.00101	0.00364	CcSEcCtD
Ergonovine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00101	0.00364	CcSEcCtD
Ergonovine—Dizziness—Raloxifene—osteoporosis	0.00101	0.00363	CcSEcCtD
Ergonovine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00101	0.00362	CcSEcCtD
Ergonovine—Vomiting—Estropipate—osteoporosis	0.001	0.00361	CcSEcCtD
Ergonovine—Dizziness—Ibandronate—osteoporosis	0.001	0.0036	CcSEcCtD
Ergonovine—Headache—Estropipate—osteoporosis	0.000989	0.00355	CcSEcCtD
Ergonovine—Vomiting—Alendronate—osteoporosis	0.000989	0.00355	CcSEcCtD
Ergonovine—Abdominal pain—Risedronate—osteoporosis	0.000986	0.00355	CcSEcCtD
Ergonovine—Muscle spasms—Estradiol—osteoporosis	0.000984	0.00354	CcSEcCtD
Ergonovine—Hypotension—Conjugated Estrogens—osteoporosis	0.000975	0.0035	CcSEcCtD
Ergonovine—Headache—Alendronate—osteoporosis	0.000974	0.0035	CcSEcCtD
Ergonovine—Vomiting—Raloxifene—osteoporosis	0.000973	0.00349	CcSEcCtD
Ergonovine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00097	0.00349	CcSEcCtD
Ergonovine—Dyspnoea—Zoledronate—osteoporosis	0.000966	0.00347	CcSEcCtD
Ergonovine—Vomiting—Ibandronate—osteoporosis	0.000963	0.00346	CcSEcCtD
Ergonovine—Headache—Raloxifene—osteoporosis	0.000958	0.00344	CcSEcCtD
Ergonovine—Headache—Ibandronate—osteoporosis	0.000949	0.00341	CcSEcCtD
Ergonovine—Vomiting—Calcitriol—osteoporosis	0.000942	0.00339	CcSEcCtD
Ergonovine—Nausea—Estropipate—osteoporosis	0.000938	0.00337	CcSEcCtD
Ergonovine—Abdominal pain—Pamidronate—osteoporosis	0.000938	0.00337	CcSEcCtD
Ergonovine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00093	0.00334	CcSEcCtD
Ergonovine—Headache—Calcitriol—osteoporosis	0.000929	0.00334	CcSEcCtD
Ergonovine—Nausea—Alendronate—osteoporosis	0.000924	0.00332	CcSEcCtD
Ergonovine—Vertigo—Estradiol—osteoporosis	0.000919	0.0033	CcSEcCtD
Ergonovine—Nausea—Raloxifene—osteoporosis	0.000909	0.00326	CcSEcCtD
Ergonovine—Palpitations—Estradiol—osteoporosis	0.000904	0.00325	CcSEcCtD
Ergonovine—Nausea—Ibandronate—osteoporosis	0.000899	0.00323	CcSEcCtD
Ergonovine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000886	0.00318	CcSEcCtD
Ergonovine—Hypertension—Estradiol—osteoporosis	0.000883	0.00317	CcSEcCtD
Ergonovine—Nausea—Calcitriol—osteoporosis	0.00088	0.00316	CcSEcCtD
Ergonovine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000876	0.00315	CcSEcCtD
Ergonovine—Chest pain—Estradiol—osteoporosis	0.000871	0.00313	CcSEcCtD
Ergonovine—Abdominal pain—Zoledronate—osteoporosis	0.000857	0.00308	CcSEcCtD
Ergonovine—Diarrhoea—Risedronate—osteoporosis	0.000854	0.00307	CcSEcCtD
Ergonovine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000853	0.00307	CcSEcCtD
Ergonovine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000846	0.00304	CcSEcCtD
Ergonovine—Dizziness—Risedronate—osteoporosis	0.000825	0.00297	CcSEcCtD
Ergonovine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000825	0.00296	CcSEcCtD
Ergonovine—Shock—Estradiol—osteoporosis	0.000822	0.00295	CcSEcCtD
Ergonovine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000814	0.00292	CcSEcCtD
Ergonovine—Diarrhoea—Pamidronate—osteoporosis	0.000812	0.00292	CcSEcCtD
Ergonovine—Hyperhidrosis—Estradiol—osteoporosis	0.000807	0.0029	CcSEcCtD
Ergonovine—Headache—Ethinyl Estradiol—osteoporosis	0.000802	0.00288	CcSEcCtD
Ergonovine—Vomiting—Risedronate—osteoporosis	0.000793	0.00285	CcSEcCtD
Ergonovine—Dizziness—Pamidronate—osteoporosis	0.000784	0.00282	CcSEcCtD
Ergonovine—Headache—Risedronate—osteoporosis	0.000782	0.00281	CcSEcCtD
Ergonovine—Nausea—Ethinyl Estradiol—osteoporosis	0.00076	0.00273	CcSEcCtD
Ergonovine—Vomiting—Pamidronate—osteoporosis	0.000754	0.00271	CcSEcCtD
Ergonovine—Dyspnoea—Estradiol—osteoporosis	0.000744	0.00268	CcSEcCtD
Ergonovine—Headache—Pamidronate—osteoporosis	0.000743	0.00267	CcSEcCtD
Ergonovine—Diarrhoea—Zoledronate—osteoporosis	0.000741	0.00266	CcSEcCtD
Ergonovine—Nausea—Risedronate—osteoporosis	0.000741	0.00266	CcSEcCtD
Ergonovine—Dizziness—Zoledronate—osteoporosis	0.000717	0.00258	CcSEcCtD
Ergonovine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000714	0.00257	CcSEcCtD
Ergonovine—Nausea—Pamidronate—osteoporosis	0.000705	0.00253	CcSEcCtD
Ergonovine—Dizziness—Conjugated Estrogens—osteoporosis	0.00069	0.00248	CcSEcCtD
Ergonovine—Vomiting—Zoledronate—osteoporosis	0.000689	0.00248	CcSEcCtD
Ergonovine—Gastrointestinal pain—Estradiol—osteoporosis	0.000683	0.00245	CcSEcCtD
Ergonovine—Headache—Zoledronate—osteoporosis	0.000679	0.00244	CcSEcCtD
Ergonovine—Vomiting—Conjugated Estrogens—osteoporosis	0.000663	0.00238	CcSEcCtD
Ergonovine—Abdominal pain—Estradiol—osteoporosis	0.00066	0.00237	CcSEcCtD
Ergonovine—Headache—Conjugated Estrogens—osteoporosis	0.000654	0.00235	CcSEcCtD
Ergonovine—Nausea—Zoledronate—osteoporosis	0.000644	0.00231	CcSEcCtD
Ergonovine—Nausea—Conjugated Estrogens—osteoporosis	0.00062	0.00223	CcSEcCtD
Ergonovine—Diarrhoea—Estradiol—osteoporosis	0.000571	0.00205	CcSEcCtD
Ergonovine—Dizziness—Estradiol—osteoporosis	0.000552	0.00198	CcSEcCtD
Ergonovine—Vomiting—Estradiol—osteoporosis	0.000531	0.00191	CcSEcCtD
Ergonovine—Headache—Estradiol—osteoporosis	0.000523	0.00188	CcSEcCtD
Ergonovine—Nausea—Estradiol—osteoporosis	0.000496	0.00178	CcSEcCtD
Ergonovine—HTR1E—GPCR downstream signaling—PTH—osteoporosis	2.54e-05	0.0046	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	2.51e-05	0.00453	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CNR2—osteoporosis	2.48e-05	0.00448	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	2.46e-05	0.00446	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CALCR—osteoporosis	2.44e-05	0.00441	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTH1R—osteoporosis	2.44e-05	0.00441	CbGpPWpGaD
Ergonovine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.38e-05	0.00431	CbGpPWpGaD
Ergonovine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	2.38e-05	0.0043	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.37e-05	0.00429	CbGpPWpGaD
Ergonovine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.35e-05	0.00425	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PTH—osteoporosis	2.31e-05	0.00418	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—PTH—osteoporosis	2.26e-05	0.0041	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.26e-05	0.00408	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CNR2—osteoporosis	2.25e-05	0.00407	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CALCR—osteoporosis	2.21e-05	0.004	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTH1R—osteoporosis	2.21e-05	0.004	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CNR2—osteoporosis	2.21e-05	0.00399	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—WNT1—osteoporosis	2.12e-05	0.00383	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—PTHLH—osteoporosis	2.11e-05	0.00381	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—WNT1—osteoporosis	2.07e-05	0.00375	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CALCR—osteoporosis	2.07e-05	0.00375	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTH1R—osteoporosis	2.07e-05	0.00375	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MGLL—osteoporosis	2.06e-05	0.00373	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—LRP5—osteoporosis	2.01e-05	0.00364	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.95e-05	0.00353	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—MGLL—osteoporosis	1.93e-05	0.0035	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.93e-05	0.00349	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.93e-05	0.00348	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—LRP6—osteoporosis	1.93e-05	0.00348	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—PTH—osteoporosis	1.92e-05	0.00348	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PTHLH—osteoporosis	1.91e-05	0.00346	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CALCR—osteoporosis	1.88e-05	0.0034	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTH1R—osteoporosis	1.88e-05	0.0034	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CNR2—osteoporosis	1.88e-05	0.00339	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—PTHLH—osteoporosis	1.88e-05	0.00339	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CALCA—osteoporosis	1.86e-05	0.00336	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—WNT1—osteoporosis	1.76e-05	0.00319	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MGLL—osteoporosis	1.76e-05	0.00318	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—POMC—osteoporosis	1.72e-05	0.00311	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.69e-05	0.00305	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CALCA—osteoporosis	1.68e-05	0.00305	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CALCA—osteoporosis	1.65e-05	0.00299	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—MGLL—osteoporosis	1.65e-05	0.00298	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TLN1—osteoporosis	1.63e-05	0.00294	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—PTHLH—osteoporosis	1.6e-05	0.00289	CbGpPWpGaD
Ergonovine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.58e-05	0.00286	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.49e-05	0.0027	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MGLL—osteoporosis	1.49e-05	0.0027	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SOST—osteoporosis	1.44e-05	0.00261	CbGpPWpGaD
Ergonovine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.43e-05	0.00259	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CALCA—osteoporosis	1.4e-05	0.00254	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—P4HB—osteoporosis	1.4e-05	0.00254	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.38e-05	0.0025	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTH—osteoporosis	1.36e-05	0.00247	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RAP1A—osteoporosis	1.34e-05	0.00243	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CNR2—osteoporosis	1.33e-05	0.00241	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.32e-05	0.0024	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—ADCY5—osteoporosis	1.32e-05	0.00239	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFATC1—osteoporosis	1.31e-05	0.00237	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CALCR—osteoporosis	1.31e-05	0.00236	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTH1R—osteoporosis	1.31e-05	0.00236	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DKK1—osteoporosis	1.3e-05	0.00235	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTH—osteoporosis	1.28e-05	0.00231	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.27e-05	0.0023	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—WNT1—osteoporosis	1.25e-05	0.00226	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CNR2—osteoporosis	1.25e-05	0.00226	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOST—osteoporosis	1.23e-05	0.00222	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—FGA—osteoporosis	1.22e-05	0.0022	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—ADCY5—osteoporosis	1.2e-05	0.00217	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTH—osteoporosis	1.16e-05	0.0021	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.16e-05	0.0021	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.13e-05	0.00205	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CNR2—osteoporosis	1.13e-05	0.00205	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—BMP2—osteoporosis	1.13e-05	0.00204	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTHLH—osteoporosis	1.13e-05	0.00204	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	1.11e-05	0.00201	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CALCR—osteoporosis	1.11e-05	0.00201	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—FGB—osteoporosis	1.11e-05	0.002	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	1.09e-05	0.00197	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.08e-05	0.00195	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PSMA5—osteoporosis	1.07e-05	0.00193	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PSMA2—osteoporosis	1.07e-05	0.00193	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—WNT1—osteoporosis	1.06e-05	0.00193	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	1.06e-05	0.00192	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTHLH—osteoporosis	1.06e-05	0.00192	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MGLL—osteoporosis	1.04e-05	0.00188	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.03e-05	0.00186	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.02e-05	0.00185	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LRP5—osteoporosis	1.01e-05	0.00183	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.01e-05	0.00183	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TNF—osteoporosis	1e-05	0.00182	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CALCA—osteoporosis	9.95e-06	0.0018	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTH—osteoporosis	9.88e-06	0.00179	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—POMC—osteoporosis	9.71e-06	0.00176	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LRP6—osteoporosis	9.69e-06	0.00175	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	9.65e-06	0.00175	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	9.63e-06	0.00174	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTHLH—osteoporosis	9.63e-06	0.00174	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PKM—osteoporosis	9.44e-06	0.00171	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—FDPS—osteoporosis	9.44e-06	0.00171	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CALCA—osteoporosis	9.33e-06	0.00169	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	9.05e-06	0.00164	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KL—osteoporosis	9.04e-06	0.00163	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	9.01e-06	0.00163	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PGLS—osteoporosis	8.95e-06	0.00162	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPD2—osteoporosis	8.95e-06	0.00162	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	8.85e-06	0.0016	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MGLL—osteoporosis	8.83e-06	0.0016	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—POMC—osteoporosis	8.81e-06	0.00159	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—POMC—osteoporosis	8.64e-06	0.00156	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LRP5—osteoporosis	8.61e-06	0.00156	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6R—osteoporosis	8.6e-06	0.00156	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CALCA—osteoporosis	8.48e-06	0.00153	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LRP6—osteoporosis	8.24e-06	0.00149	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	8.19e-06	0.00148	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PNP—osteoporosis	8.18e-06	0.00148	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ATIC—osteoporosis	8.18e-06	0.00148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TLN1—osteoporosis	8.18e-06	0.00148	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	7.94e-06	0.00144	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—POMC—osteoporosis	7.35e-06	0.00133	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	7.21e-06	0.0013	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADCY5—osteoporosis	7.08e-06	0.00128	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—P4HB—osteoporosis	7.06e-06	0.00128	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CA2—osteoporosis	6.96e-06	0.00126	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—OXCT1—osteoporosis	6.96e-06	0.00126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TLN1—osteoporosis	6.96e-06	0.00126	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTH—osteoporosis	6.86e-06	0.00124	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SPP1—osteoporosis	6.85e-06	0.00124	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MGLL—osteoporosis	6.78e-06	0.00123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RAP1A—osteoporosis	6.74e-06	0.00122	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CNR2—osteoporosis	6.69e-06	0.00121	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.66e-06	0.0012	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	6.64e-06	0.0012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFATC1—osteoporosis	6.58e-06	0.00119	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DKK1—osteoporosis	6.53e-06	0.00118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—WNT1—osteoporosis	6.29e-06	0.00114	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IRS2—osteoporosis	6.19e-06	0.00112	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—POMC—osteoporosis	6.17e-06	0.00112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGA—osteoporosis	6.12e-06	0.00111	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—LEP—osteoporosis	6.06e-06	0.0011	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	6.03e-06	0.00109	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—P4HB—osteoporosis	6e-06	0.00109	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTH—osteoporosis	5.84e-06	0.00106	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FDPS—osteoporosis	5.82e-06	0.00105	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PKM—osteoporosis	5.82e-06	0.00105	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ESR1—osteoporosis	5.79e-06	0.00105	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—IDH2—osteoporosis	5.77e-06	0.00104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	5.74e-06	0.00104	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	5.69e-06	0.00103	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CNR2—osteoporosis	5.69e-06	0.00103	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BMP2—osteoporosis	5.69e-06	0.00103	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.66e-06	0.00102	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	5.64e-06	0.00102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	5.59e-06	0.00101	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGB—osteoporosis	5.57e-06	0.00101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DKK1—osteoporosis	5.55e-06	0.001	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPD2—osteoporosis	5.51e-06	0.000997	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PGLS—osteoporosis	5.51e-06	0.000997	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP27A1—osteoporosis	5.42e-06	0.000981	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IRS1—osteoporosis	5.41e-06	0.000978	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	5.37e-06	0.000972	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	5.37e-06	0.000972	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—WNT1—osteoporosis	5.35e-06	0.000967	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.32e-06	0.000962	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.31e-06	0.00096	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ACP5—osteoporosis	5.27e-06	0.000954	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—POMC—osteoporosis	5.21e-06	0.000942	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGA—osteoporosis	5.2e-06	0.000941	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	5.13e-06	0.000927	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6R—osteoporosis	5.08e-06	0.000919	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ATIC—osteoporosis	5.04e-06	0.000912	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PNP—osteoporosis	5.04e-06	0.000912	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IGF1—osteoporosis	5.01e-06	0.000906	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CALCA—osteoporosis	5.01e-06	0.000906	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.97e-06	0.000899	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.96e-06	0.000896	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TPI1—osteoporosis	4.9e-06	0.000887	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	4.88e-06	0.000883	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	4.84e-06	0.000875	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	4.84e-06	0.000875	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGB—osteoporosis	4.73e-06	0.000856	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—P4HB—osteoporosis	4.61e-06	0.000834	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	4.57e-06	0.000826	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	4.57e-06	0.000826	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KL—osteoporosis	4.55e-06	0.000822	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GAPDH—osteoporosis	4.52e-06	0.000818	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—POMC—osteoporosis	4.43e-06	0.000802	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—RAP1A—osteoporosis	4.41e-06	0.000797	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	4.33e-06	0.000782	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—OXCT1—osteoporosis	4.29e-06	0.000776	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CA2—osteoporosis	4.29e-06	0.000776	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	4.26e-06	0.00077	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MGLL—osteoporosis	4.18e-06	0.000756	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	4.15e-06	0.000751	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KL—osteoporosis	3.87e-06	0.000699	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—osteoporosis	3.83e-06	0.000693	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	3.77e-06	0.000682	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	3.68e-06	0.000665	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ENO1—osteoporosis	3.56e-06	0.000644	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	3.56e-06	0.000644	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—IDH2—osteoporosis	3.55e-06	0.000643	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PSMA2—osteoporosis	3.51e-06	0.000635	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PSMA5—osteoporosis	3.51e-06	0.000635	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SPP1—osteoporosis	3.45e-06	0.000623	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.34e-06	0.000604	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ACP5—osteoporosis	3.25e-06	0.000588	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS2—osteoporosis	3.12e-06	0.000564	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—osteoporosis	3.05e-06	0.000552	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	3.03e-06	0.000548	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TPI1—osteoporosis	3.02e-06	0.000546	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—osteoporosis	3.01e-06	0.000545	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—osteoporosis	3e-06	0.000543	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	2.93e-06	0.00053	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—osteoporosis	2.91e-06	0.000527	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP19A1—osteoporosis	2.85e-06	0.000515	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—P4HB—osteoporosis	2.84e-06	0.000514	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GAPDH—osteoporosis	2.79e-06	0.000504	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS1—osteoporosis	2.72e-06	0.000492	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—RAP1A—osteoporosis	2.71e-06	0.000491	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	2.65e-06	0.000479	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—POMC—osteoporosis	2.62e-06	0.000474	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—osteoporosis	2.59e-06	0.000469	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6R—osteoporosis	2.56e-06	0.000462	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—osteoporosis	2.52e-06	0.000456	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	2.48e-06	0.000448	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADCY5—osteoporosis	2.33e-06	0.000421	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX1—osteoporosis	2.32e-06	0.000419	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	2.31e-06	0.000418	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—osteoporosis	2.26e-06	0.000409	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—POMC—osteoporosis	2.23e-06	0.000403	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ENO1—osteoporosis	2.19e-06	0.000397	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	2.17e-06	0.000393	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PSMA2—osteoporosis	2.16e-06	0.000391	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PSMA5—osteoporosis	2.16e-06	0.000391	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	2.14e-06	0.000388	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—osteoporosis	2.14e-06	0.000387	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.93e-06	0.000349	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.75e-06	0.000317	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—POMC—osteoporosis	1.71e-06	0.00031	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	1.64e-06	0.000296	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—osteoporosis	1.51e-06	0.000274	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	1.51e-06	0.000273	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADCY5—osteoporosis	1.43e-06	0.000259	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX1—osteoporosis	1.43e-06	0.000258	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—osteoporosis	1.32e-06	0.000238	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—osteoporosis	1.29e-06	0.000233	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	1.28e-06	0.000232	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—osteoporosis	1.14e-06	0.000206	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—POMC—osteoporosis	1.05e-06	0.000191	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—osteoporosis	9.68e-07	0.000175	CbGpPWpGaD
